To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.

Pfizer

Status and phase: Completed; Phase 2

Conditions: Epilepsy, Partial

Treatments: Drug: Pregabalin

Study type: Interventional

Funder types: Industry

Identifiers

NCT00141414

1008-008

Details and patient eligibility

About

To evaluate the long-term safety of pregabalin in refractory partial epilepsy.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Must have met the inclusion criteria for preceding double-blind study.
• Have received double-blind study medication and wish to receive open-label pregabalin.

Exclusion criteria

• Pregnant or considering becoming pregnant.
• Receiving any concomitant medication that could alter the effectiveness of their medication response or seizure frequency.

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)